A TLR7 agonist enhances the anti-tumour efficacy of obinutuzumab through an NK cell/CD4 dependent mechanism in a murine lymphoma model
EUROPEAN JOURNAL OF CANCER（2016）
Key words
tlr7 agonist,obinutuzumab,lymphoma,nk cell/cd4,cell/cd4 dependent mechanism,anti-tumour
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined